Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.

Alessandro Gronchi, Rosalba Miceli, Elizabeth Shurell, Fritz C. Eilber, Frederick R. Eilber, Daniel A. Anaya, Michael W. Kattan, Charles Honoré, Dina C. Lev, Chiara Colombo, Sylvie Bonvalot, Luigi Mariani, Raphael E. Pollock

Research output: Contribution to journalArticle

Abstract

Integration of numerous prognostic variables not included in the conventional staging of retroperitoneal soft tissue sarcomas (RPS) is essential in providing effective treatment. The purpose of this study was to build a specific nomogram for predicting postoperative overall survival (OS) and disease-free survival (DFS) in patients with primary RPS. Data registered in three institutional prospective sarcoma databases were used. We included patients with primary localized RPS resected between 1999 and 2009. Univariate (Kaplan and Meier plots) and multivariate (Cox model) analyses were carried out. The a priori chosen prognostic covariates were age, tumor size, grade, histologic subtype, multifocality, quality of surgery, and radiation therapy. External validation was performed by applying the nomograms to the patients of an external cohort. The model's discriminative ability was estimated by means of the bootstrap-corrected Harrell C statistic. In all, 523 patients were identified at the three institutions (developing set). At a median follow-up of 45 months (interquartile range, 22 to 72 months), 171 deaths were recorded. Five- and 7-year OS rates were 56.8% (95% CI, 51.4% to 62.6%) and 46.7% (95% CI, 39.9% to 54.6%. Two hundred twenty-one patients had disease recurrence. Five- and 7-year DFS rates were 39.4% (95% CI, 34.5% to 45.0%) and 35.7% (95% CI, 30.3% to 42.1%). The validation set consisted of 135 patients who were identified at the fourth institution for external validation. The bootstrap-corrected Harrell C statistics for OS and DFS were 0.74 and 0.71 in the developing set and 0.68 and 0.69 in the validating set. These nomograms accurately predict OS and DFS. They should be used for patient counseling in clinical practice and stratification in clinical trials.

Original languageEnglish
Pages (from-to)1649-1655
Number of pages7
JournalJournal of Clinical Oncology
Volume31
Issue number13
DOIs
Publication statusPublished - May 1 2013

Fingerprint

Nomograms
Sarcoma
Disease-Free Survival
Histology
Survival
Survival Rate
Aptitude
Datasets
Proportional Hazards Models
Counseling
Radiotherapy
Clinical Trials
Databases
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Outcome prediction in primary resected retroperitoneal soft tissue sarcoma : histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. / Gronchi, Alessandro; Miceli, Rosalba; Shurell, Elizabeth; Eilber, Fritz C.; Eilber, Frederick R.; Anaya, Daniel A.; Kattan, Michael W.; Honoré, Charles; Lev, Dina C.; Colombo, Chiara; Bonvalot, Sylvie; Mariani, Luigi; Pollock, Raphael E.

In: Journal of Clinical Oncology, Vol. 31, No. 13, 01.05.2013, p. 1649-1655.

Research output: Contribution to journalArticle

Gronchi, Alessandro ; Miceli, Rosalba ; Shurell, Elizabeth ; Eilber, Fritz C. ; Eilber, Frederick R. ; Anaya, Daniel A. ; Kattan, Michael W. ; Honoré, Charles ; Lev, Dina C. ; Colombo, Chiara ; Bonvalot, Sylvie ; Mariani, Luigi ; Pollock, Raphael E. / Outcome prediction in primary resected retroperitoneal soft tissue sarcoma : histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. In: Journal of Clinical Oncology. 2013 ; Vol. 31, No. 13. pp. 1649-1655.
@article{80f6e27752c344c4aceabe3bfef09c6b,
title = "Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.",
abstract = "Integration of numerous prognostic variables not included in the conventional staging of retroperitoneal soft tissue sarcomas (RPS) is essential in providing effective treatment. The purpose of this study was to build a specific nomogram for predicting postoperative overall survival (OS) and disease-free survival (DFS) in patients with primary RPS. Data registered in three institutional prospective sarcoma databases were used. We included patients with primary localized RPS resected between 1999 and 2009. Univariate (Kaplan and Meier plots) and multivariate (Cox model) analyses were carried out. The a priori chosen prognostic covariates were age, tumor size, grade, histologic subtype, multifocality, quality of surgery, and radiation therapy. External validation was performed by applying the nomograms to the patients of an external cohort. The model's discriminative ability was estimated by means of the bootstrap-corrected Harrell C statistic. In all, 523 patients were identified at the three institutions (developing set). At a median follow-up of 45 months (interquartile range, 22 to 72 months), 171 deaths were recorded. Five- and 7-year OS rates were 56.8{\%} (95{\%} CI, 51.4{\%} to 62.6{\%}) and 46.7{\%} (95{\%} CI, 39.9{\%} to 54.6{\%}. Two hundred twenty-one patients had disease recurrence. Five- and 7-year DFS rates were 39.4{\%} (95{\%} CI, 34.5{\%} to 45.0{\%}) and 35.7{\%} (95{\%} CI, 30.3{\%} to 42.1{\%}). The validation set consisted of 135 patients who were identified at the fourth institution for external validation. The bootstrap-corrected Harrell C statistics for OS and DFS were 0.74 and 0.71 in the developing set and 0.68 and 0.69 in the validating set. These nomograms accurately predict OS and DFS. They should be used for patient counseling in clinical practice and stratification in clinical trials.",
author = "Alessandro Gronchi and Rosalba Miceli and Elizabeth Shurell and Eilber, {Fritz C.} and Eilber, {Frederick R.} and Anaya, {Daniel A.} and Kattan, {Michael W.} and Charles Honor{\'e} and Lev, {Dina C.} and Chiara Colombo and Sylvie Bonvalot and Luigi Mariani and Pollock, {Raphael E.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1200/JCO.2012.44.3747",
language = "English",
volume = "31",
pages = "1649--1655",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "13",

}

TY - JOUR

T1 - Outcome prediction in primary resected retroperitoneal soft tissue sarcoma

T2 - histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.

AU - Gronchi, Alessandro

AU - Miceli, Rosalba

AU - Shurell, Elizabeth

AU - Eilber, Fritz C.

AU - Eilber, Frederick R.

AU - Anaya, Daniel A.

AU - Kattan, Michael W.

AU - Honoré, Charles

AU - Lev, Dina C.

AU - Colombo, Chiara

AU - Bonvalot, Sylvie

AU - Mariani, Luigi

AU - Pollock, Raphael E.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Integration of numerous prognostic variables not included in the conventional staging of retroperitoneal soft tissue sarcomas (RPS) is essential in providing effective treatment. The purpose of this study was to build a specific nomogram for predicting postoperative overall survival (OS) and disease-free survival (DFS) in patients with primary RPS. Data registered in three institutional prospective sarcoma databases were used. We included patients with primary localized RPS resected between 1999 and 2009. Univariate (Kaplan and Meier plots) and multivariate (Cox model) analyses were carried out. The a priori chosen prognostic covariates were age, tumor size, grade, histologic subtype, multifocality, quality of surgery, and radiation therapy. External validation was performed by applying the nomograms to the patients of an external cohort. The model's discriminative ability was estimated by means of the bootstrap-corrected Harrell C statistic. In all, 523 patients were identified at the three institutions (developing set). At a median follow-up of 45 months (interquartile range, 22 to 72 months), 171 deaths were recorded. Five- and 7-year OS rates were 56.8% (95% CI, 51.4% to 62.6%) and 46.7% (95% CI, 39.9% to 54.6%. Two hundred twenty-one patients had disease recurrence. Five- and 7-year DFS rates were 39.4% (95% CI, 34.5% to 45.0%) and 35.7% (95% CI, 30.3% to 42.1%). The validation set consisted of 135 patients who were identified at the fourth institution for external validation. The bootstrap-corrected Harrell C statistics for OS and DFS were 0.74 and 0.71 in the developing set and 0.68 and 0.69 in the validating set. These nomograms accurately predict OS and DFS. They should be used for patient counseling in clinical practice and stratification in clinical trials.

AB - Integration of numerous prognostic variables not included in the conventional staging of retroperitoneal soft tissue sarcomas (RPS) is essential in providing effective treatment. The purpose of this study was to build a specific nomogram for predicting postoperative overall survival (OS) and disease-free survival (DFS) in patients with primary RPS. Data registered in three institutional prospective sarcoma databases were used. We included patients with primary localized RPS resected between 1999 and 2009. Univariate (Kaplan and Meier plots) and multivariate (Cox model) analyses were carried out. The a priori chosen prognostic covariates were age, tumor size, grade, histologic subtype, multifocality, quality of surgery, and radiation therapy. External validation was performed by applying the nomograms to the patients of an external cohort. The model's discriminative ability was estimated by means of the bootstrap-corrected Harrell C statistic. In all, 523 patients were identified at the three institutions (developing set). At a median follow-up of 45 months (interquartile range, 22 to 72 months), 171 deaths were recorded. Five- and 7-year OS rates were 56.8% (95% CI, 51.4% to 62.6%) and 46.7% (95% CI, 39.9% to 54.6%. Two hundred twenty-one patients had disease recurrence. Five- and 7-year DFS rates were 39.4% (95% CI, 34.5% to 45.0%) and 35.7% (95% CI, 30.3% to 42.1%). The validation set consisted of 135 patients who were identified at the fourth institution for external validation. The bootstrap-corrected Harrell C statistics for OS and DFS were 0.74 and 0.71 in the developing set and 0.68 and 0.69 in the validating set. These nomograms accurately predict OS and DFS. They should be used for patient counseling in clinical practice and stratification in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84884557274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884557274&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.44.3747

DO - 10.1200/JCO.2012.44.3747

M3 - Article

C2 - 23530096

AN - SCOPUS:84884557274

VL - 31

SP - 1649

EP - 1655

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 13

ER -